1. Home
  2. ESPR vs ESQ Comparison

ESPR vs ESQ Comparison

Compare ESPR & ESQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Esperion Therapeutics Inc.

ESPR

Esperion Therapeutics Inc.

HOLD

Current Price

$3.09

Market Cap

898.5M

Sector

Health Care

ML Signal

HOLD

Logo Esquire Financial Holdings Inc.

ESQ

Esquire Financial Holdings Inc.

HOLD

Current Price

$107.34

Market Cap

858.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ESPR
ESQ
Founded
2008
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Commercial Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
898.5M
858.2M
IPO Year
2013
2017

Fundamental Metrics

Financial Performance
Metric
ESPR
ESQ
Price
$3.09
$107.34
Analyst Decision
Buy
Hold
Analyst Count
6
3
Target Price
$6.67
$113.00
AVG Volume (30 Days)
5.6M
53.0K
Earning Date
03-03-2026
01-23-2026
Dividend Yield
N/A
0.66%
EPS Growth
N/A
14.70
EPS
N/A
5.68
Revenue
$303,802,000.00
$131,743,000.00
Revenue This Year
$26.11
N/A
Revenue Next Year
N/A
$18.55
P/E Ratio
N/A
$18.81
Revenue Growth
2.83
13.37
52 Week Low
$0.69
$68.90
52 Week High
$4.18
$134.82

Technical Indicators

Market Signals
Indicator
ESPR
ESQ
Relative Strength Index (RSI) 32.93 54.62
Support Level $3.00 $103.23
Resistance Level $4.18 $107.87
Average True Range (ATR) 0.23 2.67
MACD -0.11 -0.03
Stochastic Oscillator 4.26 59.25

Price Performance

Historical Comparison
ESPR
ESQ

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About ESQ Esquire Financial Holdings Inc.

Esquire Financial Holdings Inc is a financial holding company. Through its subsidiary, the company operates as a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. In addition, it operates a payment processing platform through third-party independent sales organizations.

Share on Social Networks: